Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 275

1.

Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo.

Versiani M, Nardi AE, Figueira IL, Stabl M.

Acta Psychiatr Scand Suppl. 1990;360:24-8.

PMID:
2123366
2.

Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.

Lecrubier Y, Guelfi JD.

Acta Psychiatr Scand Suppl. 1990;360:18-23.

PMID:
2248063
3.

RIMA--a new concept in the treatment of depression with moclobemide.

Amrein R, Hetzel W, Stabl M, Schmid-Burgk W.

Int Clin Psychopharmacol. 1993 Jan;7(3-4):123-32. Review.

PMID:
8468432
4.

Moclobemide: therapeutic use and clinical studies.

Bonnet U.

CNS Drug Rev. 2003 Spring;9(1):97-140. Review.

5.

Switch in treatment from tricyclic antidepressants to moclobemide: a new generation monoamine oxidase inhibitor.

Dingemanse J, Kneer J, Fotteler B, Groen H, Peeters PA, Jonkman JH.

J Clin Psychopharmacol. 1995 Feb;15(1):41-8.

PMID:
7714227
6.

RIMA: a safe concept in the treatment of depression with moclobemide.

Amrein R, Hetzel W, Stabl M, Schmid-Burgk W.

Can J Psychiatry. 1992 Sep;37 Suppl 1:7-11. Review.

PMID:
1394030
7.

Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.

Ucha Udabe R, Márquez CA, Traballi CA, Portes N.

Acta Psychiatr Scand Suppl. 1990;360:54-6.

PMID:
2123367
9.

Moclobemide. An update of its pharmacological properties and therapeutic use.

Fulton B, Benfield P.

Drugs. 1996 Sep;52(3):450-74. Review. Erratum in: Drugs 1996 Dec;52(6):869.

PMID:
8875133
10.

Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.

Stabl M, Biziére K, Schmid-Burgk W, Amrein R.

J Neural Transm Suppl. 1989;28:77-89. Review.

PMID:
2677244
11.

[Multicenter study comparing efficacy and tolerance of moclobemide and fluvoxamine in hospitalized and ambulatory patients with severe depressive episodes].

Barrelet L, Blajev B, Bolzani L, de Saussure C, Kasas A, Van H, Gachoud JP.

Schweiz Rundsch Med Prax. 1991 May 7;80(19):524-8. French.

PMID:
1904620
12.

Moclobemide, imipramine and placebo in the treatment of major depression.

Versiani M, Nardi AE, Mundim FD, Alves A, Schmid-Burgk W.

Acta Psychiatr Scand Suppl. 1990;360:57-8.

PMID:
2248073
13.
14.

Moclobemide--placebo-controlled trials.

Silverstone T.

Int Clin Psychopharmacol. 1993 Jan;7(3-4):133-6. Review.

PMID:
8468433
15.

Tyramine pressor response with moclobemide--a reversible monoamine oxidase inhibitor.

Tiller JW, Maguire KP, Davies BM.

Psychiatry Res. 1987 Nov;22(3):213-20.

PMID:
3432450
16.
17.

Reversible and selective inhibitors of monoamine oxidase A in the treatment of depressed elderly patients.

Nair NP, Ahmed SK, Kin NM, West TE.

Acta Psychiatr Scand Suppl. 1995;386:28-35. Review.

PMID:
7717092
18.

The efficacy of reversible monoamine oxidase inhibitors in depressive illness.

Roth M, Guelfi JD.

Can J Psychiatry. 1992 Sep;37 Suppl 1:18-24.

PMID:
1394027
19.
20.

Supplemental Content

Support Center